Demonstrates the feasibility of percutaneous transvenous antegrade mitral valve-in-valve implantation using a Melody valve in a high-surgical-risk patient.
We report a case of transcatheter valve-in-valve therapy performed on an 85-year-old man with severe mitral bioprosthetic valve dysfunction. He was a high risk candidate for conventional surgery and he underwent placement of the Melody transcatheter heart valve into the mitral bioprosthesis via the right femoral vein.
Michelena et al. (Mon,) studied this question.